title: Poly(adenosine diphosphate-ribosylation) of nuclear matrix proteins in alkylating agent resistant and sensitive cell lines.
abstract: Using Walker 256 breast carcinoma cell lines either with or without acquired resistance to alkylating agents, the structural framework proteins of the nucleus, the nuclear matrix proteins, were found to be effective acceptors for poly(ADP-ribose). Incubation of isolated nuclei with nicotinamide adenine [32P] dinucleotide ([32P] NAD), followed by the isolation of the nuclear matrix, demonstrated that two polypeptides of approximate molecular weight (Mr) 105 000 and 116 000 were extensively poly(ADP-ribosylated). By an in vitro [32P] NAD assay, the nuclear matrix fraction was found to maintain approx. 15% of the total nuclear matrix activity of poly(ADP-ribose) polymerase. Confirmation that the trichloroacetic acid (TCA) precipitable material represented ADP-ribose units was achieved by enzymatic digestion of the nuclear matrix preparation with snake venom phosphodiesterase (SVP). Within 15 min, greater than 85% of the 32P label was digested by SVP and the final digestion products were found to be phosphoribosyl-AMP (PR-AMP) and adenosine 5'-monophosphate (5'-AMP) by thin layer chromatographic analysis. The average polymer chain length was estimated to be 6-7 ADP-ribose units. Because poly(ADP-ribose) polymerase has a putative role in DNA repair, a comparison of the nuclear matrix fractions from Walker resistant and sensitive tumor cell lines was made. In both cell lines, the quantitative and qualitative patterns of the nuclear matrix associated poly(ADP-ribosylation) were similar.
authors.forename: B C
authors.initials: BC
authors.lastname: Moy
authors.forename: K D
authors.initials: KD
authors.lastname: Tew
mesh_terms: D000249:Adenosine Monophosphate / Q000378:metabolism; D000818:Animals; D034961:Antigens, Nuclear; D002279:Carcinoma 256, Walker / Q000378:metabolism; D002460:Cell Line; D002855:Chromatography, Thin Layer; D003850:Deoxyribonuclease I / Q000378:metabolism; D004351:Drug Resistance; D004591:Electrophoresis, Polyacrylamide Gel; D008325:Mammary Neoplasms, Experimental / Q000378:metabolism; D008466:Mechlorethamine / Q000494:pharmacology; D008854:Microscopy, Electron; D008970:Molecular Weight; D009243:NAD / Q000378:metabolism; D009698:Nucleoproteins / Q000378:metabolism*; D009702:Nucleoside Diphosphate Sugars / Q000378:metabolism*; D043264:Phosphodiesterase I; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D011064:Poly Adenosine Diphosphate Ribose / Q000378:metabolism*; D011065:Poly(ADP-ribose) Polymerases / Q000378:metabolism; D012259:Ribonuclease, Pancreatic / Q000378:metabolism
chemical_list: D034961:Antigens, Nuclear; D009698:Nucleoproteins; D009702:Nucleoside Diphosphate Sugars; D009243:NAD; D011064:Poly Adenosine Diphosphate Ribose; D000249:Adenosine Monophosphate; D008466:Mechlorethamine; D011065:Poly(ADP-ribose) Polymerases; D003850:Deoxyribonuclease I; D012259:Ribonuclease, Pancreatic; D010727:Phosphoric Diester Hydrolases; D043264:Phosphodiesterase I; C470790:phosphodiesterase I, snake venom